BFH-25937-37989
5 vaccinations
6 coded responses
47 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 640 / MO
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-09
- 2021-01-11
- 2021-01-12
- 2021-01-15
- 2021-01-21
-
2021-01-27
Dose 2 — Pfizer-BioNTech
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 2MedDRA: Abdominal pain, Chills, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chills, headache, fatigue, abdominal pain for 4 hours then better afterwards. No fever or cough. No known exposure to anyone sick since home isolated due to weather for 1 week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: Good · HeadacheFree text: Clear runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — day 7, dose 3MedDRA: Cough, Rhinorrhoea — Feeling: Good · Muscle or body achesFree text: Clear runny nose, occasional coughMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-10-29
Survey response — day 35, dose 3MedDRA: Chills, Cough, Diarrhoea, Dyspnoea, Fatigue, Headache, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chills, headache, mild shortness of breath, fatigue, body aches,diarrhea, dry coughMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-12-24
- 2022-03-25
-
2022-04-08
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-08
-
2022-09-17
Dose 5 — Moderna
-
2022-10-07
Survey response — 6 months, dose 4MedDRA: Fatigue, Headache — Feeling: GoodFree text: Had fatigue and headache for 5 days after receiving my 3rd booster of the new Moderna 3 weeks agoMedDRA releases: 2024-11 · check-in free text available
- 2022-10-16
- 2022-10-23
- 2022-10-29
- 2022-12-17
-
2023-03-18
Survey response — 6 months, dose 5MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-18
Report sent to call center — 6 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-17 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 14, dose 2
Symptoms: Chills, headache, fatigue, abdominal pain for 4 hours then better afterwards. No fever or cough. No known exposure to anyone sick since home isolated due to weather for 1 week.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Clear runny nose
Release 9 — day 7, dose 3
Systemic reaction (other): Clear runny nose, occasional cough
Release 10 — day 35, dose 3
Symptoms: Chills, headache, mild shortness of breath, fatigue, body aches,diarrhea, dry cough
Release 12 — 6 months, dose 4
Symptoms: Had fatigue and headache for 5 days after receiving my 3rd booster of the new Moderna 3 weeks ago
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release